Tailored interventions for harmful alcohol and drug use in hospital patients
Implementation of Tailored Interventions to Treat Harmful Alcohol and Drug Use for Medical Patients in Norwegian Hospitals and the Municipality Service - AlcoTail
This study is testing whether personalized support for patients with harmful alcohol and drug use in the hospital can lead to better health outcomes compared to standard care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 4200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Oslo University Hospital Academic / other |
| Locations | 1 site (Oslo) |
| Trial ID | NCT04957628 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the implementation and real-world effects of tailored interventions for harmful alcohol consumption and psychoactive drug use among hospital inpatients. It involves screening patients for alcohol use and providing evidence-based interventions based on their consumption levels. The study will compare outcomes between a control group of 2500 patients receiving standard care and a case group of 2500 patients receiving the new intervention protocols. The aim is to improve health outcomes by addressing harmful substance use in acute medical settings.
Who should consider this trial
Good fit: Ideal candidates for this study are hospital inpatients admitted to medical wards who are able to understand Norwegian.
Not a fit: Patients who are cognitively or mentally unable to consent, or those admitted for injury or planned surgery, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved health outcomes for patients by reducing harmful alcohol and drug use.
How similar studies have performed: Other studies have shown success with similar interventions aimed at reducing harmful substance use in hospital settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients admitted to Medical wards Exclusion Criteria: * Inability to understand written and verbal Norwegian * Cognitive or mental inability to consent to participation * Injury or planned surgery as primary reason for admission
Where this trial is running
Oslo
- Oslo University Hospital — Oslo, Norway (Recruiting)
Study contacts
- Study coordinator: Anners Lerdal, PhD
- Email: anners.lerdal@medisin.uio.no
- Phone: 23 22 50 00
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.